NCT04026919 (OKenCASA) is a NA clinical trial of OK EN CASA-ZAINDOO in Effect Increased, sponsored by University of the Basque Country (UPV/EHU).

Who is sponsoring NCT04026919?

NCT04026919 is sponsored by University of the Basque Country (UPV/EHU).

What drugs are being tested in NCT04026919?

Interventions in NCT04026919: OK EN CASA-ZAINDOO.

What condition does NCT04026919 study?

NCT04026919 studies Effect Increased.

Is NCT04026919 still recruiting?

NCT04026919 is currently status unknown. Last updated 19 July 2019.

Last reviewed 2019-07-19 · How we verify

NCT04026919: OKenCASA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Online Support Program for Dementia Caregivers

Status unknown NA Last updated 19 July 2019

What this trial tests

NA trial testing OK EN CASA-ZAINDOO in Effect Increased in 250 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
1 March 2020

1 March 2020

Quick facts

Lead sponsor	University of the Basque Country (UPV/EHU)
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	250
Start date	1 September 2018
Primary completion	1 March 2020
Estimated completion	1 March 2020
Sites	2 locations across Spain

Drugs / interventions tested

OK EN CASA-ZAINDOO

Conditions studied

Effect Increased — all drugs for Effect Increased →

Sponsor

University of the Basque Country (UPV/EHU)

Who can join

Eligibility, any sex, with Effect Increased. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are currently 50 million people in the world diagnosed with dementia. Due to the detrimental impact on the mental and physical health of family caregivers different online interventions have been developed in order to improve their well-being. In this paper, we describe the design of a randomized controlled trial aiming to study the impact of a multicomponent online program on primary and secondary caregivers of a person with dementia (PWD). The experimental group will receive the intervention which is a multicomponent program based on different components, among others; online psychoeducation, training on psychological skills, a forum with other caregivers and interaction with a psychologist. Caregivers in the control group will follow their lifestyle. More than 250 participants (primary and secondary caregivers) are expected to be recruited via several sources in the province of Guipuzcoa in Spain. The inclusion criteria for the primary caregiver are: a) being 18 years or older; b) being the primary caregiver of the PWD; c) more than 6 months caring; and d) give more than 1 hour of caregiving per day. The outcomes of this trial are caregiver burden (primary outcome), perceived health, depression and anxiety, social support, satisfaction with care and with the treatment and stress caused by the problem behaviour of the PWD (secondary outcomes).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Remotely delivered information, training and support for informal caregivers of people with dementia.
González-Fraile E, Ballesteros J, Rueda JR, Santos-Zorrozúa B, et al · · 2021 · cited 54× · PMID 33417236 · DOI 10.1002/14651858.cd006440.pub3

Verify or expand the search:

Other University of the Basque Country (UPV/EHU) trials

Trials by the same sponsor.

NCT07498881 — LasaiON is an Evidence-informed, Multimodal Self-regulation Program Designed to Reduce Emotional Distress and Strengthen · NA · not yet recruiting
NCT07228507 — Video Intervention of Relative Energy Deficiency in Sport · NA · completed
NCT06352749 — Face-to-face vs Online Physical Exercise in Seniors Living in Nursing Homes (ExerMOT-NH) · NA · recruiting
NCT06114394 — Complications Related to Palatal Graft Harvesting · NA · enrolling by invitation
NCT06220110 — Probiotic Supplementation on Sport Performance and Gut Damage in Females · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04026919 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of the Basque Country (UPV/EHU)
Last refreshed: 19 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04026919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing